AU2016323769B2 - Compositions comprising pregnancy specific glycoproteins and methods of use thereof - Google Patents

Compositions comprising pregnancy specific glycoproteins and methods of use thereof Download PDF

Info

Publication number
AU2016323769B2
AU2016323769B2 AU2016323769A AU2016323769A AU2016323769B2 AU 2016323769 B2 AU2016323769 B2 AU 2016323769B2 AU 2016323769 A AU2016323769 A AU 2016323769A AU 2016323769 A AU2016323769 A AU 2016323769A AU 2016323769 B2 AU2016323769 B2 AU 2016323769B2
Authority
AU
Australia
Prior art keywords
leu
amino acid
ser
pro
thr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2016323769A
Other languages
English (en)
Other versions
AU2016323769A1 (en
Inventor
Gabriela DVEKSLER
Harry MALECH
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Henry M Jackson Foundation for Advancedment of Military Medicine Inc
US Department of Health and Human Services
Original Assignee
Henry M Jackson Foundation for Advancedment of Military Medicine Inc
Government of the United States of America
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henry M Jackson Foundation for Advancedment of Military Medicine Inc, Government of the United States of America filed Critical Henry M Jackson Foundation for Advancedment of Military Medicine Inc
Publication of AU2016323769A1 publication Critical patent/AU2016323769A1/en
Application granted granted Critical
Publication of AU2016323769B2 publication Critical patent/AU2016323769B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/1774—Immunoglobulin superfamily (e.g. CD2, CD4, CD8, ICAM molecules, B7 molecules, Fc-receptors, MHC-molecules)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Transplantation (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2016323769A 2015-09-17 2016-09-16 Compositions comprising pregnancy specific glycoproteins and methods of use thereof Active AU2016323769B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562219900P 2015-09-17 2015-09-17
US62/219,900 2015-09-17
PCT/US2016/052131 WO2017049082A2 (en) 2015-09-17 2016-09-16 Compositions comprising pregnancy specific glycoproteins and methods of use thereof

Publications (2)

Publication Number Publication Date
AU2016323769A1 AU2016323769A1 (en) 2017-10-19
AU2016323769B2 true AU2016323769B2 (en) 2022-05-26

Family

ID=58289625

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2016323769A Active AU2016323769B2 (en) 2015-09-17 2016-09-16 Compositions comprising pregnancy specific glycoproteins and methods of use thereof

Country Status (6)

Country Link
US (2) US11007249B2 (enExample)
EP (1) EP3261722B1 (enExample)
JP (1) JP2018529625A (enExample)
AU (1) AU2016323769B2 (enExample)
CA (1) CA2981191C (enExample)
WO (1) WO2017049082A2 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022219008A1 (en) 2021-04-14 2022-10-20 University College Cork - National University Of Ireland, Cork Treatment of cerebrovascular events and neurological disorders
JP2024514194A (ja) 2021-04-14 2024-03-28 ユニバーシティ・カレッジ・コークーナショナル・ユニバーシティ・オブ・アイルランド，コーク 変形性関節症の治療に使用するためのｐｓｇ１
WO2024078729A1 (en) 2022-10-14 2024-04-18 University College Cork - National University Of Ireland, Cork Placenta expressed proteins for use in the treatment of tendon injury

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
EP0154316B1 (en) 1984-03-06 1989-09-13 Takeda Chemical Industries, Ltd. Chemically modified lymphokine and production thereof
EP0401384B1 (en) 1988-12-22 1996-03-13 Kirin-Amgen, Inc. Chemically modified granulocyte colony stimulating factor
US5169835A (en) 1989-01-18 1992-12-08 Oklahoma Medical Research Foundation Pregancy specific proteins applications
US5252714A (en) 1990-11-28 1993-10-12 The University Of Alabama In Huntsville Preparation and use of polyethylene glycol propionaldehyde
EP1578366A4 (en) * 2002-10-09 2007-12-19 Tolerrx Inc MOLECULES PREFERABLY ASSOCIATED WITH EFFECTOR T CELLS OR REGULATORY T CELLS AND METHODS OF USE THEREOF
US9005616B2 (en) 2009-08-31 2015-04-14 Amplimmune, Inc. Methods and compositions for the inhibition of transplant rejection

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Carli et al. (Biol Blood Marrow Transplant 18: 1329-1340 (2012)). *

Also Published As

Publication number Publication date
AU2016323769A1 (en) 2017-10-19
US11007249B2 (en) 2021-05-18
EP3261722B1 (en) 2021-04-14
WO2017049082A3 (en) 2017-05-04
WO2017049082A2 (en) 2017-03-23
CA2981191C (en) 2022-09-13
JP2018529625A (ja) 2018-10-11
CA2981191A1 (en) 2017-03-23
EP3261722A2 (en) 2018-01-03
USRE50535E1 (en) 2025-08-19
US20180177844A1 (en) 2018-06-28
EP3261722A4 (en) 2018-11-21

Similar Documents

Publication Publication Date Title
US12091441B2 (en) Partial agonists of interleukin-2
KR102653758B1 (ko) 인터류킨-2/인터류킨-2 수용체 알파 융합 단백질 및 사용 방법
US9840545B2 (en) Fusion protein comprising interleukin-2 and interleukin-33
AU2003267563A1 (en) Pharmaceutical composition and medical treatments comprising notch ligand proteins
AU2016323769B2 (en) Compositions comprising pregnancy specific glycoproteins and methods of use thereof
JP2023106434A (ja) 制御性ｔ細胞エピトープ
EP1525221A1 (en) Conjugate of notch signalling pathway modulators and their use in medical treatment
CN114686429B (zh) 一种激活nk细胞的肿瘤免疫治疗方法
US20230036793A1 (en) Interleukin 2 chimeric constructs
KR20220044683A (ko) 관절염 치료를 위한 hla-dr/cii 펩티드 복합체
EP3191186B1 (en) Compositions and methods of using interleukin-4 induced gene 1 (il4i1)
KR20240007197A (ko) 자가면역 및 동종면역 질환의 예방 및/또는 치료를 위한 면역억제성 항원-특이적 키메릭 항원 수용체 조절 t 세포
US20210309707A1 (en) Interferon-gamma biased agonists
WO2001002003A1 (en) Method of treating psoriasis with il-15 antagonist
EP2931293B1 (en) Compositions and methods for regulating erythropoiesis
WO2021160170A1 (en) Methods of use of soluble cd24 for treating sars-cov-2 infection
EP3790571B1 (en) Peptides derived from oca-b for use in the treatment of autoimmune diseases and of leukemia
EP2032601B1 (en) Peptides regulating the surface expression of the t cell receptor
JP2006503899A (ja) ＴＧＦ−βの遮断により腫瘍再発を防ぐ方法
CA3225321A1 (en) Ptprs in autoimmunity

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)